Clinical Trial Update: Twice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating twice-daily amoxicillin for non-severe community-acquired pneumonia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Community-acquired Pneumonia | Phase 2, Phase 3 | Status: RECRUITING